title: [Vincristine-bleomycin-methotrexate in the treatment of recurrence of ORL carcinoma].
authors: M
authors: M
authors: Airoldi
authors: F
authors: F
authors: Pedani
authors: P
authors: P
authors: Gabriell
authors: C
authors: C
authors: Giordano
authors: F
authors: F
authors: Pia
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy*; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D014750:Vincristine; D008727:Methotrexate
vernacular_title: Vincristina-bleomicina-methotrexate nel trattamento delle recidive dei carcinomi ORL.